Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of V419/PR5I versus Infanrix hexa in healthy infants
2010-021491-28Phase 3Completed
- Sponsor
- Sanofi Pasteur MSD S.N.C.
- Start
- Jun 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of haemophilus influenzae type b vaccine in diphtheria, Tetanus, pertussis and 3 more (2 arms), sponsored by Sanofi Pasteur MSD S.N.C. Primary endpoint: Vaccine-induced antibody response. Started Jun 2011; status: completed.
02
Drugs
haemophilus influenzae type b vaccine
03
Conditions
diphtheriaTetanuspertussispoliomyelitisHaemophilus influenzae type b disease (Hib)
Beyond the preview
Go deeper on 2010-021491-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021491-28.